<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ALLO
Allogene Therapeutics
$
()


  • Allogene Therapeutics management to meet with Truist

    3/20/2024 - 04:55am
  • Allogene Therapeutics management to meet with Truist

    3/19/2024 - 04:55am
  • Allogene Therapeutics management to meet with Truist

    3/18/2024 - 16:22pm
  • JPMorgan biotech/pharma analysts hold an analyst/industry conference call

    3/15/2024 - 12:03pm
  • Allogene Therapeutics files $500M mixed securities shelf

    3/14/2024 - 17:22pm
  • Allogene Therapeutics sees $190M reduction in cash in 2024

    3/14/2024 - 16:29pm
  • Allogene Therapeutics reports Q4 EPS (51c), consensus (45c)

    3/14/2024 - 16:28pm
  • Allogene, Arbor enter global gene editing license agreement

    3/12/2024 - 08:41am
  • Allogene Therapeutics management to meet with Truist

    3/7/2024 - 04:55am
  • Allogene Therapeutics management to meet with Truist

    3/6/2024 - 05:55am
  • Allogene Therapeutics management to meet with Truist

    3/5/2024 - 04:55am
  • Allogene Therapeutics management to meet with Truist

    3/4/2024 - 10:24am
  • Allogene Therapeutics to restate previously filed financial statements

    2/16/2024 - 08:35am
  • Allogene Therapeutics price target lowered by $2 at H.C. Wainwright, here's why

    1/19/2024 - 06:20am
  • Allogene Therapeutics price target lowered by $1 at Truist, here's why

    1/8/2024 - 07:34am
dynamic_feed Breaking News